Clinical Trials Browser

Unknown × Observational × Antineoplastic Agents × Clear all

Cardiovascular Diseases, Heart Diseases, Neoplasms, Vascular Diseases

NCT03882580 2023-04-24

NEOCARDIO

Heart Diseases, Heart Failure, Metabolic Diseases, Vascular Diseases, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

NCT05728788 2023-03-03

Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy

Unknown

50 enrolled

Cancer Therapy-related Cardiovascular Toxicity

NCT05486988 2022-08-04

ctDNA as a Biomarker for Treatment in Advanced NSCLC

Unknown

500 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04696250 2021-01-06

AVATAR

Unknown

5,000,000 enrolled

Tumor-Agnostic

Neoplasms

NCT04663438 2020-12-11

Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLC

Unknown

300 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT04115410 2020-05-28

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

Unknown

4,724 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03923036 2019-04-22

AVOCETTE

Unknown

2,000 enrolled

Gastrointestinal

Colorectal Cancer Metastatic

Clinical Trials

PARCA

NEOCARDIO

Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy

ctDNA as a Biomarker for Treatment in Advanced NSCLC

AVATAR

Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLC

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

AVOCETTE